Circio logoCircio logo

  • About
    About
    Close
      • About Circio
      • Pipeline
      • Management Team
      • Board of Directors
      • Careers
  • circRNA
    circRNA
    Close
      • Circio AB
      • circVec platform
  • Clinical programs
    Clinical programs
    Close
      • ONCOS-102
      • KRAS program
      • Publications
  • Partnering
  • Investors
    Investors
    Close
      • Press releases
      • Events
      • Financial Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
        • General Meetings
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Articles of Association
      • Contact
  • Media
    Media
    Close
      • Press releases
      • Events
      • Subscribe
      • Contact
  • Contacts
    Contacts
    Close
      • Offices
      • Investors & Media
    • About
      • About Circio
      • Our pipeline
      • Management Team
      • Board of Directors
      • Collaborations
      • Careers
    • circRNA
      • Circio AB
      • circVec platform
    • Clinical programs
      • ONCOS-102
      • KRAS program
      • Publications
    • Partnering
      • Partnering
    • Investors
      • Press releases
      • Events
      • Financial Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
      • General Meetings
      • Board of Directors
      • Nomination Committee
      • Committees
      • Management
      • Articles of Association
      • Contact
      • Subscribe
      • Contact
    • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
    • Contacts
      • Offices
      • Investors & Media
    All press releases
    • Press releases - Regulatory
    • Press releases - Non-regulatory
    2019
    • 2023
    • 2022
    • 2021
    • 2020
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • All years
    All subjects
    • Corporate news
    • Other
    December 19, 2019
    Press release - Regulatory

    Targovax ASA issues options to employees

    November 28, 2019
    Press release - Regulatory

    Targovax ASA: Primary insider share purchase

    November 11, 2019
    Press release - Non-regulatory

    Presentation of ONCOS-102 melanoma data at SITC Annual Meeting

    November 7, 2019
    Press release - Regulatory

    Targovax ASA: Third quarter 2019 results

    October 29, 2019
    Press release - Non-regulatory

    Targovax ASA: Invitation to presentation of Targovax’s third quarter 2019 results, Thursday 7 November

    October 9, 2019
    Press release - Non-regulatory

    Targovax selected for oral presentation at Society for Immunotherapy of Cancer (SITC) 2019 Annual Meeting

    September 24, 2019
    Press release - Non-regulatory

    Targovax announces opening of Oslo University Hospital as site for ONCOS-102 trial in melanoma

    September 18, 2019
    Press release - Regulatory

    Correction: Targovax Q2 2019 report

    August 22, 2019
    Press release - Regulatory

    Targovax ASA: Second quarter and first half 2019 results

    August 12, 2019
    Press release - Non-regulatory

    Targovax ASA: Announcement of second quarter and first half results 2019

    July 31, 2019
    Press release - Non-regulatory

    Targovax is invited to present at Solebury Trout European Biotech Investor Day in NYC

    July 15, 2019
    Press release - Non-regulatory

    Targovax announces start of the expansion part in the phase I/II trial with ONCOS-102 in combination with durvalumab in patients with advanced peritoneal malignancies

    July 9, 2019
    Press release - Regulatory

    Targovax ASA: Notification of trade by primary insiders

    July 8, 2019
    Press release - Regulatory

    Targovax announces encouraging results from part 1 of the ONCOS-102 and Keytruda combination trial in anti-PD1 refractory melanoma

    June 18, 2019
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following settlement of RSUs

    June 13, 2019
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider following settlement of RSUs

    June 12, 2019
    Press release - Regulatory

    Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

    June 6, 2019
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

    June 6, 2019
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

    June 5, 2019
    Press release - Regulatory

    Targovax ASA: Completion of subsequent offering, registration of share capital increase

    June 3, 2019
    Press release - Non-regulatory

    Targovax announces publication of in vivo abscopal effect of ONCOS-102 and Keytruda combination

    May 31, 2019
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

    May 28, 2019
    Press release - Regulatory

    Targovax ASA: Final result of the subsequent offering

    May 24, 2019
    Press release - Regulatory

    Targovax ASA: Last day of the subscription period in the subsequent offering

    May 23, 2019
    Press release - Regulatory

    TARGOVAX ASA – APPROVAL AND PUBLICATION OF SUPPLEMENTAL PROSPECTUS

    May 23, 2019
    Press release - Regulatory

    Targovax to fully focus on ONCOS oncolytic virus program

    May 23, 2019
    Press release - Regulatory

    Targovax announces median and three-year overall survival for TG01 trial in resected pancreatic cancer

    May 10, 2019
    Press release - Regulatory

    Targovax ASA: Commencement of subscription period in the subsequent offering

    May 9, 2019
    Press release - Regulatory

    Targovax ASA: First quarter 2019 results

    May 8, 2019
    Press release - Non-regulatory

    Targovax announces completed enrollment of ONCOS-102 trial in mesothelioma

    May 2, 2019
    Press release - Regulatory

    Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

    April 30, 2019
    Press release - Regulatory

    Targovax ASA: Minutes from the Annual General Meeting

    April 30, 2019
    Press release - Non-regulatory

    Targovax ASA: Announcement of first quarter 2019

    April 12, 2019
    Press release - Regulatory

    TARGOVAX ASA – APPROVAL AND PUBLICATION OF SUPPLEMENTAL PROSPECTUS

    April 9, 2019
    Press release - Regulatory

    Targovax ASA: Annual Report 2018

    April 9, 2019
    Press release - Regulatory

    Notice of Annual General Meeting

    March 28, 2019
    Press release - Regulatory

    TARGOVAX ASA – REGISTRATION OF SHARE CAPITAL INCREASE FOLLOWING THE PRIVATE PLACEMENT

    March 27, 2019
    Press release - Regulatory

    TARGOVAX ASA – APPROVAL AND PUBLICATION OF PROSPECTUS

    March 25, 2019
    Press release - Regulatory

    Targovax to hold a webcast with Q&A session

    March 21, 2019
    Press release - Regulatory

    TARGOVAX ASA – NOTIFICATION OF SHAREHOLDING

    March 21, 2019
    Press release - Regulatory

    TARGOVAX ASA – KEY INFORMATION RELATED TO THE SUBSEQUENT OFFERING

    March 21, 2019
    Press release - Regulatory

    TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT

    March 21, 2019
    Press release - Regulatory

    TARGOVAX ASA – CONTEMPLATED PRIVATE PLACEMENT

    March 19, 2019
    Press release - Non-regulatory

    Targovax is invited to present at Neoantigen Summit Europe, DNB SME Conference and BIO-Europe Spring

    March 15, 2019
    Press release - Regulatory

    Targovax signs clinical collaboration agreement with the Parker Institute for Cancer Immunotherapy and Cancer Research Institute

    March 14, 2019
    Press release - Non-regulatory

    Targovax grants Zelluna Immunotherapy an FTO license to intellectual property relating to mutant RAS T cell receptor technology

    March 8, 2019
    Press release - Non-regulatory

    Targovax announces Notice of Allowance in the US on patent covering the TG mutant-RAS neoantigen vaccine platform

    February 14, 2019
    Press release - Regulatory

    Targovax ASA: Fourth quarter and full year 2018 results

    February 11, 2019
    Press release - Non-regulatory

    First patient treated in dose expansion cohort of Targovax’s ONCOS-102 trial in melanoma

    February 4, 2019
    Press release - Non-regulatory

    Targovax ASA: Announcement of fourth quarter and full year results 2018

    January 21, 2019
    Press release - Non-regulatory

    Targovax is invited to present at upcoming investor conferences

    January 17, 2019
    Press release - Non-regulatory

    Targovax granted European Patent for mutant-RAS neoantigen platform lead products

    January 3, 2019
    Press release - Regulatory

    Targovax ASA issues options to employees

    IR contact
    Dr Lubor Gaal
    Dr Lubor Gaal
    Chief Financial Officer
    lubor.gaal@circio.com
    (+34) 683 343 811
    Renate Birkeli
    Renate Birkeli
    Investor Relations
    renate.birkeli@circio.com
    (+47) 922 61 624
    • PRINT
    • STAY CONNECTED
    • Cookies
    • Privacy policy